Extracorporeal Membrane Oxygenation Machine Market Size

  • Report ID: 5525
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Extracorporeal Membrane Oxygenation Machine Market Size

Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 527.02 million in 2024 and is set to exceed USD 899.72 million by 2037, expanding at over 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of extracorporeal membrane oxygenation machine is evaluated at USD 544.73 million.

The primary growth driver for the market is the increasing prevalence of respiratory disorders. Respiratory diseases such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, and pneumonia are on the rise worldwide. Therefore, extracorporeal membrane oxygenation machine which provide vital life support to patients with compromised lung function, have witnessed a substantial surge.

According to the World Health Organization (WHO),  respiratory system-related diseases are responsible for global morbidity and mortality.

Traditional ventilator support is proved to be insufficient in severe respiratory failure cases. Moreover, the extracorporeal membrane oxygenation machine provide advanced respiratory assistance by oxygenating the blood outside the body. Further, the ECMO machine market can experience a hike due to events such as pandemics or large-scale health crises since these machine are crucial in supporting patients with severe respiratory distress.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5525
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of extracorporeal membrane oxygenation machine is evaluated at USD 544.73 million.

The extracorporeal membrane oxygenation machine market size was valued at USD 527.02 million in 2024 and is set to exceed USD 899.72 million by 2037, expanding at over 4.2% CAGR during the forecast period i.e., between 2025-2037. Technological investments are driving innovation in the healthcare sector, global health events, and extensive utilization of ECMO applications in trauma cases will drive the market growth.

Asia Pacific industry is poised to dominate majority revenue share of 36% by 2037, impelled by research and development in the pharmaceutical sector in the region.

The major players in the market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG, Microport Scientific Corporation, Eurosets S.r.l., Johnson & Johnson, Abbott, Fresenius Medical Care
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample